Revaprazan Hydrochloride CAS 178307-42-1 Assay ≥99.0% API Nadiifnimada Sare ee Warshada
Magaca Kiimikada: Revaprazan Hydrochloride;Revaprazan HCL
CAS: 178307-42-1
API Tayada Sare, Wax soo saarka Ganacsiga
Magaca Kiimikada | Revaprazan Hydrochloride |
La mid ah | Revaprazan HCL |
Lambarka CAS | 178307-42-1 |
Lambarka CAT | RF-API48 |
Heerka Saamiyada | Kaydka, Miisaanka Wax-soo-saarka Ilaa boqollaal Kiilogaram |
Qaanuunka molecular | C22H24ClFN4 |
Miisaanka Molecular | 398.904 |
Summada | Kiimikada Ruifu |
Shayga | Tilmaamaha |
Muuqashada | Caddaan ama Banaan-cad budada Crystalline |
Solubility | Si xor ah ugu milmay chloroform, dichlormeth;Ku milmay acid acetic;In yar oo ku milma methanol, DMSO;Si adag ugu milma acetone, ACN;Ku dhawaad aan lagu milmin 0.1mol/L NaOH0.1mol/L HCL xal. |
Aqoonsiga | Waa in si togan looga jawaabaa λ max 271nm, 205nm IR |
Meesha dhalaalaysa | 219.0 ~ 222.0 ℃ |
Cadaynta iyo Midabka | Waa inuu ahaadaa mid cad oo aan midab lahayn dichlormeth |
Chloride | ≤8.93% |
Xumaanta Keliya | ≤0.10% |
Wadarta wasakhda | ≤0.50% |
Khasaare xagga qalajinta | ≤0.50% |
Hadhaaga dabka | ≤0.10% |
Sulfate | ≤20pm |
Arsenic | ≤10pm |
Biraha culus | ≤10pm |
Qiimayn | ≥99.0% |
Heerka Imtixaanka | Heerka Ganacsiga |
Isticmaalka | Walaxda Farmashiyeedka Firfircoon (API) |
Xidhmada: Dhalo, boorsada aluminium aluminium, durbaanka kartoonada, 25kg/Drum, ama sida waafaqsan shuruudaha macmiilka.
Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka, qoyaanka iyo cayayaanka.
Shanghai Ruifu Chemical Co., Ltd. waa saaraha iyo soo saaraha ugu horreeya ee Revaprazan Hydrochloride (CAS: 178307-42-1) oo leh tayo sare leh.Revaprazan Hydrochloride waxay yaraynaysaa COX-2 muujinta waxayna leedahay waxqabadyo ficil ah oo ka-hortagga bararka ee caabuqa H. pylori.Revaprazan Hydrochloride ee daaweynta boogaha duodenal, boogaha gastric iyo gastritis.
Revaprazan Hydrochloride (oo sidoo kale loo yaqaanno dib-u-celinta proton pump inhibitors, potassium competitive acid blockers, p-CABs) waa jiil cusub oo celin kara bamka bamka proton iyo kuwa kaliya ee ganacsi ahaan la heli karo ee xakameeyayaasha bamka aashitada potassium ama antagonists bamka aashitada adduunka.Waxaa soo saartay shirkadda Kuuriyada Koonfureed Yuhan oo leh xuquuqaha lahaanshaha garaadka, GLAxoSmithKline waxay heshay shatiyo horumarineed iyo suuqgeyn caalami ah oo dawada ka baxsan Koonfurta Kuuriya iyo Waqooyiga Kuuriya.Daawada waxaa ansixiyay FDA South Korea 2007 si loogu daweeyo boogaha duodenal iyo gastritis.